June Raine Britain covid-19 vaccine medicines June Raine Britain

UK regulator to assess best dose regimen of Oxford Covid-19 vaccine

Reading now: 351
www.livemint.com

LONDON : Britain's medical regulator will examine all the data from trials of the Covid-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator's chief executive said on Wednesday."Our regulatory review is all encompassing.

We will look at all available data," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), told lawmakers after a study showed the vaccine had efficacy of 62% for trial participants given two full doses, but 90% for a smaller sub-group given a half, then a full dose."Clearly, we have great interest into the possible reasons for the different doses having a different efficacy...

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA